肠道噬菌体与细菌和宿主互作及其对动物机体健康影响的研究进展

doi:10.11843/j.issn.0366-6964.2019.01.002

摘要/Abstract

摘要：

近年来肠道病毒组功能研究日益受到关注，其中肠道噬菌体作为肠道病毒组的主要组成，更是成为了研究热点。大量研究表明，肠道噬菌体种类和数量不仅直接影响肠道微生物菌群区系，还与动物机体存在着密切联系，因此对动物机体健康发挥着重要作用。本文就肠道噬菌体研究进展进行总结，从肠道噬菌体、噬菌体与细菌互作、噬菌体与动物宿主互作以及肠道噬菌体与肠道炎症性疾病、代谢性疾病等疾病的联系等方面进行综述，为深入研究肠道噬菌体对机体健康的影响及其机制提供理论参考和新的思路。

Abstract:

In recent years, the research on the function of gut virome has attracted increasing attention. As a main component of the gut virome, intestinal phage has become a research hotspot. Numerous studies have shown that the diversity and abundance of gut phage not only directly affect the gut microbiota, but also have close correlation with host function, playing an important role in modulation of host health. In this review, we summarize current research progress in the interaction between gut phage and bacteria, the interaction between phage and animal host, and the relationship between gut phage and diseases such as inflammatory bowel disease and metabolic disease. This review will provide a theoretical basis and new perspective for further study on the effect of gut phage on animal health.

中图分类号:

S852.6

周贝, 林焱, 朱伟云. 肠道噬菌体与细菌和宿主互作及其对动物机体健康影响的研究进展[J]. 畜牧兽医学报, 2019, 50(1): 14-20.

ZHOU Bei, LIN Yan, ZHU Weiyun. Advances in the Interaction among Gut Phage, Bacteria and Host and Its Impacts on the Animal Host Health[J]. ACTA VETERINARIA ET ZOOTECHNICA SINICA, 2019, 50(1): 14-20.

0
/ / 推荐

导出引用管理器 EndNote|Reference Manager|ProCite|BibTeX|RefWorks

链接本文: https://www.xmsyxb.com/CN/10.11843/j.issn.0366-6964.2019.01.002

https://www.xmsyxb.com/CN/Y2019/V50/I1/14

参考文献

[1] LLOYD-PRICE J,ABU-ALI G,HUTTENHOWER C.The healthy human microbiome[J].Genome Med,2016, 8(1):51.
[2] HOYLES L,MCCARTNEY A L,NEVE H,et al.Characterization of virus-like particles associated with the human faecal and caecal microbiota[J].Res Microbiol,2014,165(10):803-812.
[3] EDWARDS R A,ROHWER F.Viral metagenomics[J].Nat Rev Microbiol,2005,3(6):504-510.
[4] MINOT S,SINHA R,CHEN J,et al.The human gut virome:inter-individual variation and dynamic response to diet[J]. Genome Res,2011,21(10):1616-1625.
[5] REYES A,HAYNES M,HANSON N,et al.Viruses in the faecal microbiota of monozygotic twins and their mothers[J].Nature,2010,466(7304):334-338.
[6] WEINBAUER M G.Ecology of prokaryotic viruses[J].FEMS Microbiol Rev,2004,28(2):127-181.
[7] BRÜSSOW H,CANCHAYA C,CANCHAYA W D.Phages and the evolution of bacterial pathogens:from genomic rearrangements to lysogenic conversion[J].Microbiol Mol Biol Rev,2004,68(3):560-602.
[8] MIRZAEI M K,MAURICE C F.Ménage à trois in the human gut:interactions between host,bacteria and phages[J].Nat Rev Microbiol,2017,15(7):397-408.
[9] REYES A,BLANTON L V,CAO S,et al.Gut DNA viromes of Malawian twins discordant for severe acute malnutrition[J].Proc Natl Acad Sci U S A,2015,112(38):11941-11946.
[10] NORMAN J M,HANDLEY S A,BALDRIDGE M T,et al.Disease-specific alterations in the enteric virome in inflammatory bowel disease[J].Cell,2015,160(3):447-460.
[11] KIM M S,BAE J W.Spatial disturbances in altered mucosal and luminal gut viromes of diet-induced obese mice[J].Environ Microbiol,2016,18(5):1498-1510.
[12] KRISHNAMURTHY S R,JANOWSKI A B,ZHAO G Y,et al.Hyperexpansion of RNA bacteriophage diversity[J].PLoS Biol,2016,14(3):e1002409.
[13] HAVELAAR A H,FURUSE K,HOGEBOOM W M.Bacteriophages and indicator bacteria in human and animal faeces[J].J Appl Bacteriol,1986,60(3):255-262.
[14] LOOFT T,ALLEN H K,CANTAREL B L,et al.Bacteria,phages and pigs:the effects of in-feed antibiotics on the microbiome at different gut locations[J].ISME J,2014,8(8):1566-1576.
[15] ZOETENDAL E G,RAES J,VAN DEN BOGERT B,et al.The human small intestinal microbiota is driven by rapid uptake and conversion of simple carbohydrates[J].ISME J,2012,6(7):1415-1426.
[16] SHARON I,MOROWITZ M J,THOMAS B C,et al.Time series community genomics analysis reveals rapid shifts in bacterial species,strains,and phage during infant gut colonization[J].Genome Res,2013,23(1):111-120.
[17] KOENIG J E,SPOR A,SCALFONE N,et al.Succession of microbial consortia in the developing infant gut microbiome[J].Proc Natl Acad Sci U S A,2011,108(S1):4578-4585.
[18] LIM E S,ZHOU Y J,ZHAO G Y,et al.Early life dynamics of the human gut virome and bacterial microbiome in infants[J].Nat Med,2015,21(10):1228-1234.
[19] THINGSTAD T F.Elements of a theory for the mechanisms controlling abundance,diversity,and biogeochemical role of lytic bacterial viruses in aquatic systems[J].Limnol Oceanogr,2000,45(6):1320-1328.
[20] MAHANA D,TRENT C M,KURTZ Z D,et al.Antibiotic perturbation of the murine gut microbiome enhances the adiposity,insulin resistance,and liver disease associated with high-fat diet[J].Genome Med,2016,8(1):48.
[21] CHARBONNEAU M R,O'DONNELL D,BLANTON L V,et al.Sialylated milk oligosaccharides promote microbiota-dependent growth in models of infant undernutrition[J].Cell,2016,164(5):859-871.
[22] VAN HOUTE S,BUCKLING A,WESTRA E R.Evolutionary ecology of prokaryotic immune mechanisms[J].Microbiol Mol Biol Rev,2016,80(3):745-763.
[23] SAMSON J E,MAGADÁN A H,SABRI M,et al.Revenge of the phages:defeating bacterial defences[J].Nat Rev Microbiol,2013,11(10):675-687.
[24] BORGES A L,ZHANG J Y,ROLLINS M F,et al.Bacteriophage cooperation suppresses CRISPR-Cas3 and Cas9 immunity[J].Cell,2018,174(4):917-925.
[25] BARR J J,AURO R,FURLAN M,et al.Bacteriophage adhering to mucus provide a non-host-derived immunity[J].Proc Natl Acad Sci U S A,2013,110(26):10771-10776.
[26] BARR J J,AURO R,SAM-SOON N,et al.Subdiffusive motion of bacteriophage in mucosal surfaces increases the frequency of bacterial encounters[J].Proc Natl Acad Sci U S A,2015,112(44):13675-13680.
[27] BREITBART M,ROHWER F.Method for discovering novel DNA viruses in blood using viral particle selection and shotgun sequencing[J].Biotechniques,2005,39(5):729-736.
[28] MANKIEWICZ E,LⅡVAK M.Mycobacteriophages isolated from human sources[J].Nature,1967, 216(5114):485-486.
[29] MOUSTAFA A,XIE C,KIRKNESS E,et al.The blood DNA virome in 8000 humans[J].PLoS Pathog,2017, 13(3):e1006292.
[30] HAMZEH-MIVEHROUD M,MAHMOUDPOUR A,REZAZADEH H,et al.Non-specific translocation of peptide-displaying bacteriophage particles across the gastrointestinal barrier[J].Eur J Pharm Biopharm, 2008, 70(2):577-581.
[31] HILDEBRAND G J,WOLOCHOW H.Translocation of bacteriophage across the intestinal wall of the rat[J]. Proc Soc Exp Biol Med,1962,109:183-185.
[32] WEBER-DABROWSKA B,DABROWSKI M,SLOPEK S.Studies on bacteriophage penetration in patients subjected to phage therapy[J].Arch Immunol Ther Exp,1987,35(5):563-568.
[33] NGUYEN S,BAKER K,PADMAN B S,et al.Bacteriophage transcytosis provides a mechanism to cross epithelial cell layers[J].mBio,2017,8(6):e01874.
[34] HANDLEY S A,THACKRAY L B,ZHAO G Y,et al.Pathogenic simian immunodeficiency virus infection is associated with expansion of the enteric virome[J].Cell,2012,151(2):253-266.
[35] HSIA R C,OHAYON H,GOUNON P,et al.Phage infection of the obligate intracellular bacterium,Chlamydia psittaci strain Guinea pig inclusion conjunctivitis[J].Microb Infect,2000,2(7):761-772.
[36] PRANJOL M Z I,HAJITOU A.Bacteriophage-derived vectors for targeted cancer gene therapy[J].Viruses, 2015,7(1):268-284.
[37] ARONOW R,DANON D,SHAHAR A,et al.Electron microscopy of in vitro endocytosis of T² phage by cells from rabbit peritoneal exudate[J].J Exp Med,1964,120(5):943-954.
[38] ZHANG L L,SUN L C,WEI R C,et al.Intracellular Staphylococcus aureus control by virulent bacteriophages within MAC-T bovine mammary epithelial cells[J].Antimicrob Agents Chemother,2017,61(2):e01990-16.
[39] UHR J W,FINKELSTEIN M S,BAUMANN J B.Antibody formation.Ⅲ.The primary and secondary antibody response to bacteriophage phi X 174 in guinea pigs[J].J Exp Med,1962,115:655-670.
[40] UHR J W,DANCIS J,FRANKLIN E C,et al.The antibody response to bacteriophage φX 174 in newborn premature infants[J].J Clin Invest,1962,41(7):1509-1513.
[41] DBROWSKA K,MIERNIKIEWICZ P,PIOTROWICZ A,et al.Immunogenicity studies of proteins forming the T4 phage head surface[J].J Virol,2014,88(21):12551-12557.
[42] MAJEWSKA J,BETA W,LECION D,et al.Oral application of T4 phage induces weak antibody production in the gut and in the blood[J].Viruses,2015,7(8):4783-4799.
[43] GÓRSKI A,KNIOTEK M,PERKOWSKA-PTASINSKA A,et al.Bacteriophages and transplantation tolerance[J].Trans Proc,2006,38(1):331-333.
[44] GÓRSKI A,WANA E,DBROWSKA B W,et al.Bacteriophage translocation[J].FEMS Immunol Med Microbiol, 2006,46(3):313-319.
[45] MIERNIKIEWICZ P,KLOPOT A,SOLUCH R,et al.T4 phage tail adhesin Gp12 counteracts LPS-induced inflammation in vivo[J].Front Microbiol,2016,7:1112.
[46] ZIMECKI M,ARTYM J,KOCIEBA M,et al.Effects of prophylactic administration of bacteriophages to immunosuppressed mice infected with Staphylococcus aureus[J].BMC Microbiol,2009,9(1):169.
[47] CHADHA P,KATARE O P,CHHIBBER S.Liposome loaded phage cocktail:enhanced therapeutic potential in resolving Klebsiella pneumoniae mediated burn wound infections[J].Burns,2017,43(7):1532-1543.
[48] MANRIQUE P,BOLDUC B,WALK S T,et al.Healthy human gut phageome[J].Proc Natl Acad Sci U S A,2016,113(37):10400-10405.
[49] DUTILH B E,CASSMAN N,MCNAIR K,et al.A highly abundant bacteriophage discovered in the unknown sequences of human faecal metagenomes[J].Nat Commun,2014,5:4498.
[50] GROEN A K,NIEUWDORP M.An evaluation of the therapeutic potential of fecal microbiota transplantation to treat infectious and metabolic diseases[J].EMBO Mol Med,2017,9(1):1-3.
[51] BOJANOVA D P,BORDENSTEIN S R.Fecal transplants:what is being transferred?[J].PLoS Biol,2016, 14(7):e1002503.
[52] FUENTES S,VAN NOOD E,TIMS S,et al.Reset of a critically disturbed microbial ecosystem:faecal transplant in recurrent Clostridium difficile infection[J].ISME J,2014,8(8):1621-1633.
[53] GUPTA S,ALLEN-VERCOE E,PETROF E O.Fecal microbiota transplantation:in perspective[J].Ther Adv Gastroenterol,2016,9(2):229-239.
[54] ANDREWS P J,BORODY T J."Putting back the bugs":bacterial treatment relieves chronic constipation and symptoms of irritable bowel syndrome[J].Med J Aust,1993,159(9):633-634.
[55] VRIEZE A,VAN N E,HOLLEMAN F,et al.Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome[J].Gastroenterology,2012,143(4):913-916.
[56] BROECKER F,KLUMPP J,SCHUPPLER M,et al.Long-term changes of bacterial and viral compositions in the intestine of a recovered Clostridium difficile patient after fecal microbiota transplantation[J].Cold Spring Harb Mol Case Stud,2016,2(1):a000448.
[57] CHEHOUD C,DRYGA A,HWANG Y,et al.Transfer of viral communities between human individuals during fecal microbiota transplantation[J].mBio,2016,7(2):e00322.
[58] OTT S J,WAETZIG G H,REHMAN A,et al.Efficacy of sterile fecal filtrate transfer for treating patients with Clostridium difficile infection[J].Gastroenterology,2017,152(4):799-811.
[59] ZUO T,WONG S H,LAM K,et al.Bacteriophage transfer during faecal microbiota transplantation in Clostridium difficile infection is associated with treatment outcome[J].Gut,2017,67(4):634-643.
[60] ESTEVE E,RICART W,FERNÁNDEZ-REAL J M.Gut microbiota interactions with obesity,insulin resistance and type 2 diabetes:did gut microbiote co-evolve with insulin resistance?[J].Curr Opin Clin Nutr Metab Care,2011,14(5):483-490.
[61] MA Y F,YOU X Y,MAI G Q,et al.A human gut phage catalog correlates the gut phageome with type 2 diabetes[J].Microbiome,2018,6(1):24.
[62] ZHAO G Y,VATANEN T,DROIT L,et al.Intestinal virome changes precede autoimmunity in type I diabetes-susceptible children[J].Proc Natl Acad Sci U S A,2017,114(30):E6166-E6175.
[63] KOSTIC A D,GEVERS D,SILJANDER H,et al.The dynamics of the human infant gut microbiome in development and in progression toward type 1 diabetes[J].Cell Host Microbe,2015,17(2):260-273.